We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App





Messe Düsseldorf Promotes International “MEDICAlliance” Portfolio at ADLM 2024

By LabMedica International staff writers
Posted on 31 Jul 2024

Messe Düsseldorf (Düsseldorf, Germany) is participating in the ADLM Clinical Lab Expo 2024 to promote its “MEDICAlliance” program of regional and international medical trade fairs organized around the globe. More...

At ADLM booth 4421, visitor and exhibitor information are available for MEDICA 2024, World Forum for Medicine, and COMPAMED 2024, high-tech solutions for medical technology (held currently from November 11 – 14, 2024 in Düsseldorf, Germany), Medical Fair China (August 2024 in Suzhou), Medical Fair Asia and Medical Manufacturing Asia (held concurrently in September 2024 in Singapore) as well as Medical Fair Thailand (September 2025 in Bangkok) and Medical Fair India (2025 in New Delhi).

With over 5,300 exhibitors from almost 70 countries and 83,000 visitors from around the globe, MEDICA in Düsseldorf is one of the largest medical B2B trade fairs in the world. The event presents a wide range of innovative products and services from the fields of medical imaging, laboratory technology, diagnostics, health IT, and mobile health as well as physiotherapy/orthopedic technology and medical consumables. The exhibitors showcase innovations along the industry's entire value chain and for the complete workflow of modern healthcare. The extensive program of forums, conferences, and special shows complement the exhibits. On average, 800+ international IVD companies and lab equipment manufacturers have participated each year, displaying the latest global advancements in laboratory medicine, equipment, and molecular diagnostic solutions.

Related Links:
Messe Düsseldorf


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Acute lymphoblastic leukemia in children and young people requires careful relapse risk assessment as treatment expands beyond standard chemotherapy. (Image Credit: Shutterstock)

New Risk-Stratification Tool Predicts Relapse After Blinatumomab in Childhood ALL

Acute lymphoblastic leukemia in children and young people requires careful assessment of relapse risk, particularly as treatment approaches move beyond standard chemotherapy. Traditional relapse predictors... Read more

Microbiology

view channel
Image Credit: Adobe Stock

Decentralized Laboratory Network Improves Detection of Viral Hemorrhagic Fevers in Guinea

Viral hemorrhagic fevers remain a major diagnostic challenge in West Africa because their early symptoms can resemble those of other febrile illnesses. The 2014–2016 Ebola epidemic underscored the need... Read more

Pathology

view channel
Image Credit: Adobe Stock

AI Pathology Approach Closely Aligns With Breast Cancer Genomic Risk Classification

In early-stage breast cancer, precision oncology relies on biological information to guide personalized treatment decisions. Because access to tissue-based genomic testing may be limited, there is growing... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.